Limiting the number of fresh donor oocytes inseminated with sperm as a strategy to minimize supernumerary embryos.

IF 6.6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Fertility and sterility Pub Date : 2024-12-01 Epub Date: 2024-08-06 DOI:10.1016/j.fertnstert.2024.07.035
Samantha Spring, Shelun Tsai, Zoe Verzani, Steven Spandorfer
{"title":"Limiting the number of fresh donor oocytes inseminated with sperm as a strategy to minimize supernumerary embryos.","authors":"Samantha Spring, Shelun Tsai, Zoe Verzani, Steven Spandorfer","doi":"10.1016/j.fertnstert.2024.07.035","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To determine the optimal number of fresh donor oocytes to expose to sperm for patients who want to prioritize reducing surplus embryos while preserving the live birth rate.</p><p><strong>Design: </strong>Cross-sectional study.</p><p><strong>Setting: </strong>University.</p><p><strong>Patient(s): </strong>Patients who underwent their first in vitro fertilization of fresh donor oocytes at a single academic institution between January 2013 and November 2022. Patients were excluded if they used a directed oocyte donor, donor aged >32 years, gestational carrier, surgically retrieved sperm, or preimplantation genetic testing.</p><p><strong>Intervention(s): </strong>Number of fresh mature donor oocytes fertilized via intracytoplasmic sperm injection.</p><p><strong>Main outcome measure(s): </strong>The primary outcome was the number of cryopreserved supernumerary blastocysts. The number of supernumerary blastocysts was defined as the number of blastocysts remaining after the first live birth, or if the patient did not have a live birth, the number of supernumerary blastocysts was determined by the number of blastocysts remaining after the last transfer cycle. The Kruskal-Wallis rank sum test was used to determine differences in number of supernumerary blastocysts.</p><p><strong>Result(s): </strong>A total of 543 patients who underwent 750 embryo transfer cycles using fresh donor oocytes were included. The average recipient age was 42.9 ± 3.8 years, and the average oocyte donor age was 26.6 ± 3.0 years. For our cohort, patients received a median of 10 (interquartile range [IQR], 8-14) mature donor oocytes; 8 (IQR, 6-11) were injected with sperm, 4 (IQR, 3-6) usable embryos were developed, and 2 (IQR, 0-5) supernumerary blastocysts remained. Patients were then divided into four quartiles on the basis of the number of mature donor oocytes received (≤7, 8-10, 11-14, or ≥15). There was a significant increase in the median number of cryopreserved supernumerary blastocysts as the number of mature donor oocytes exposed to sperm increased (1 vs. 2 vs. 3 vs. 6 blastocysts in the first, second, third, and fourth quartiles, respectively). There were no statistically significant differences in live birth rates between the quartiles.</p><p><strong>Conclusion(s): </strong>The number of supernumerary blastocysts significantly increased as more mature donor oocytes were exposed to sperm. This study can serve as a counseling tool for patients with concerns regarding excess cryopreserved embryos when using fresh donor oocytes.</p>","PeriodicalId":12275,"journal":{"name":"Fertility and sterility","volume":" ","pages":"1048-1054"},"PeriodicalIF":6.6000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fertility and sterility","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.fertnstert.2024.07.035","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To determine the optimal number of fresh donor oocytes to expose to sperm for patients who want to prioritize reducing surplus embryos while preserving the live birth rate.

Design: Cross-sectional study.

Setting: University.

Patient(s): Patients who underwent their first in vitro fertilization of fresh donor oocytes at a single academic institution between January 2013 and November 2022. Patients were excluded if they used a directed oocyte donor, donor aged >32 years, gestational carrier, surgically retrieved sperm, or preimplantation genetic testing.

Intervention(s): Number of fresh mature donor oocytes fertilized via intracytoplasmic sperm injection.

Main outcome measure(s): The primary outcome was the number of cryopreserved supernumerary blastocysts. The number of supernumerary blastocysts was defined as the number of blastocysts remaining after the first live birth, or if the patient did not have a live birth, the number of supernumerary blastocysts was determined by the number of blastocysts remaining after the last transfer cycle. The Kruskal-Wallis rank sum test was used to determine differences in number of supernumerary blastocysts.

Result(s): A total of 543 patients who underwent 750 embryo transfer cycles using fresh donor oocytes were included. The average recipient age was 42.9 ± 3.8 years, and the average oocyte donor age was 26.6 ± 3.0 years. For our cohort, patients received a median of 10 (interquartile range [IQR], 8-14) mature donor oocytes; 8 (IQR, 6-11) were injected with sperm, 4 (IQR, 3-6) usable embryos were developed, and 2 (IQR, 0-5) supernumerary blastocysts remained. Patients were then divided into four quartiles on the basis of the number of mature donor oocytes received (≤7, 8-10, 11-14, or ≥15). There was a significant increase in the median number of cryopreserved supernumerary blastocysts as the number of mature donor oocytes exposed to sperm increased (1 vs. 2 vs. 3 vs. 6 blastocysts in the first, second, third, and fourth quartiles, respectively). There were no statistically significant differences in live birth rates between the quartiles.

Conclusion(s): The number of supernumerary blastocysts significantly increased as more mature donor oocytes were exposed to sperm. This study can serve as a counseling tool for patients with concerns regarding excess cryopreserved embryos when using fresh donor oocytes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
限制新鲜供体卵母细胞与精子人工授精的数量,以尽量减少超常胚胎。
目的确定在保持活产率的前提下优先减少多余胚胎的患者暴露于精子的新鲜捐献卵母细胞的最佳数量:横断面研究 对象: 首次接受体外受精的患者:2013 年 1 月 1 日至 2022 年 11 月期间在一家学术机构首次接受新鲜供体卵母细胞体外受精的患者。如果患者使用了定向卵母细胞捐献者、捐献者年龄超过 32 岁、妊娠携带者、手术取精或植入前基因检测,则排除在外:主要结果是冷冻保存的超数囊胚数量。超数囊胚数定义为首次活产后剩余的囊胚数,如果患者没有活产,则超数囊胚数由最后一次移植周期后剩余的囊胚数决定。采用 Kruskal-Wallis 秩和检验来确定超数囊胚数量的差异:结果:共纳入了 543 例使用新鲜供体卵母细胞进行 750 次胚胎移植的患者。受者平均年龄为(42.9±3.8)岁,卵母细胞捐献者平均年龄为(26.6±3.0)岁。在我们的队列中,患者获得的成熟供体卵母细胞中位数为 10 个(IQR 8,14 个);8 个(IQR 6,11 个)注射了精子,4 个(IQR 3,6 个)发育成可用胚胎,剩余 2 个(IQR 0,5 个)超数囊胚。然后,根据接受的成熟供体卵母细胞数量(≤7、8-10、11-14 或≥15)将患者分为四个四分位数。随着暴露于精子的成熟供体卵母细胞数量的增加,冷冻保存的超数囊胚的中位数也明显增加(第一、第二、第三和第四四分位数分别为 1 vs. 2 vs. 3 vs. 6 个囊胚):随着更多成熟供体卵母细胞暴露于精子,超数囊胚的数量明显增加。这项研究可作为一种咨询工具,帮助使用新鲜供体卵母细胞时担心冷冻胚胎过多的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Fertility and sterility
Fertility and sterility 医学-妇产科学
CiteScore
11.30
自引率
6.00%
发文量
1446
审稿时长
31 days
期刊介绍: Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.
期刊最新文献
Preimplantation Genetic Testing post-Dobbs: REI Physician Perceptions of Impact on Counseling and Patient Decision Making. Childhood adversity and doctor visits in gynaecology: to screen or not to screen. Low doses of alkylating agents do not harm human ovarian tissue destined for cryopreservation. Preconception Chlamydia trachomatis seropositivity and fecundability, live birth, and adverse pregnancy outcomes. (Not) My body, my choice?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1